Scharf Investments LLC trimmed its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 17.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,084,710 shares of the pharmacy operator’s stock after selling 447,603 shares during the period. Walgreens Boots Alliance makes up approximately 4.5% of Scharf Investments LLC’s holdings, making the stock its 11th biggest holding. Scharf Investments LLC’s holdings in Walgreens Boots Alliance were worth $125,143,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in WBA. BlueMountain Capital Management LLC acquired a new stake in Walgreens Boots Alliance during the 2nd quarter worth approximately $103,000. Squar Milner Financial Services LLC acquired a new stake in Walgreens Boots Alliance during the 2nd quarter worth approximately $106,000. Archford Capital Strategies LLC acquired a new stake in Walgreens Boots Alliance during the 1st quarter worth approximately $115,000. Kaizen Advisory LLC raised its holdings in Walgreens Boots Alliance by 128.6% during the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after buying an additional 1,083 shares during the period. Finally, Camarda Financial Advisors LLC acquired a new stake in Walgreens Boots Alliance during the 2nd quarter worth approximately $137,000. Institutional investors and hedge funds own 61.98% of the company’s stock.
In other news, insider Stefano Pessina bought 1,697,438 shares of the firm’s stock in a transaction that occurred on Monday, July 16th. The stock was acquired at an average cost of $63.92 per share, with a total value of $108,500,236.96. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total transaction of $180,548.64. Following the completion of the transaction, the director now directly owns 10,943 shares of the company’s stock, valued at $722,128.57. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by company insiders.
NASDAQ WBA opened at $67.62 on Wednesday. Walgreens Boots Alliance Inc has a 12-month low of $59.07 and a 12-month high of $83.89. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.47 and a current ratio of 0.93. The company has a market capitalization of $68.04 billion, a PE ratio of 13.26, a price-to-earnings-growth ratio of 1.12 and a beta of 1.09.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 28th. The pharmacy operator reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.06. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. The business had revenue of $34.33 billion during the quarter, compared to analysts’ expectations of $34.15 billion. During the same period last year, the business earned $1.33 earnings per share. The firm’s revenue was up 14.0% on a year-over-year basis. analysts predict that Walgreens Boots Alliance Inc will post 5.97 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 12th. Investors of record on Monday, August 20th will be paid a $0.44 dividend. The ex-dividend date of this dividend is Friday, August 17th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.40. This represents a $1.76 annualized dividend and a dividend yield of 2.60%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 34.51%.
Several brokerages have commented on WBA. BidaskClub upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, August 21st. Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Wednesday, June 20th. Cowen downgraded shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating and set a $104.00 target price on the stock. in a report on Monday, July 23rd. ValuEngine downgraded shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Tuesday, May 22nd. Finally, Leerink Swann dropped their target price on shares of Walgreens Boots Alliance from $75.00 to $70.00 and set a “market perform” rating on the stock in a report on Wednesday, May 23rd. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $77.22.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Featured Story: Average Daily Trade Volume – What You Need to Know
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.